IGF2BP2 and cancer: Second, while cancer stem-like properties are widely recognized to confer resistance to conventional therapies through mechanisms such as enhanced drug efflux or dormancy, our study did not explore the functional relationship between IGF2BP2-driven stemness and therapeutic outcomes in preclinical models.